🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: GSK Biologicals' Synflorix™ (Pneumococcal vaccine GSK1024850A)

Found 13 matching trials

Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines

PHASE3

The purpose of this observer blind study is to assess the safety in terms o...

Status

Completed

Location

GSK Investigational Site

Start Date

2007-10-22

Trial ID

NCT00547248

Treatments Being Tested

Synflorix Tritanrix-HepB Hiberix Polio Sabin Poliorix Prevenar (Wyeth)

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine

PHASE3

This study will evaluate safety, reactogenicity and immunogenicity of GSK B...

Status

Completed

Location

GSK Investigational Site

Start Date

2006-08-07

Trial ID

NCT00344318

Treatments Being Tested

Pneumococcal conjugate vaccine GSK1024850A Prevenar Tritanrix-HepB Hiberix Polio Sabin.Poliorix.

Primary Vaccination Course in Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A or Prevenar™ and Hiberix™

PHASE3

The purposes of this study are: To demonstrate the immunogenicity in terms...

Status

Completed

Location

GSK Investigational Site

Start Date

2008-06-10

Trial ID

NCT00680914

Treatments Being Tested

Pneumococcal vaccine GSK1024850A (Synflorix)Prevenar GSK Biologicals' Hiberix™

A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants

PHASE3

The primary aim of the study is to demonstrate that an investigational 4-do...

Status

Completed

Location

GSK Investigational Site

Start Date

2015-06-11

Trial ID

NCT02447432

Treatments Being Tested

Pneumococcal vaccine GSK1024850A (10Pn-PD-DiT) vaccine (4-dose presentation)Pneumococcal vaccine GSK1024850A (10Pn-PD-DiT) vaccine (1-dose presentation)DTPw-HBV/Hib

Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria

PHASE3

The purpose of this trial is to assess the safety, reactogenicity and immun...

Status

Completed

Location

GSK Investigational Site

Start Date

2010-10-04

Trial ID

NCT01153893

Treatments Being Tested

Pneumococcal vaccine GSK1024850A InfanrixTM

Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib

PHASE3

The purpose of this trial is to evaluate the immunogenicity and safety of a...

Status

Completed

Location

GSK Investigational Site

Start Date

2008-04-01

Trial ID

NCT00652951

Treatments Being Tested

GSK Biologicals´ Pneumococcal Conjugate Vaccine GSK1024850A (Synflorix™)Infanrix™ hexa.Pediacel™Prevenar™

Booster Vaccination Study With a Pneumococcal Vaccine in Children Primed With the Same Vaccine

PHASE3

The purpose of this study is to evaluate the reactogenicity, safety and imm...

Status

Completed

Location

GSK Investigational Site

Start Date

2009-06-11

Trial ID

NCT00911144

Treatments Being Tested

GSK Biologicals' Synflorix™ (Pneumococcal vaccine GSK1024850A)Wyeth-Lederle's Prevenar™GSK Biologicals' Hiberix™

Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants

PHASE3

This study aims to evaluate the safety, reactogenicity and immunogenicity o...

Status

Completed

Location

GSK Investigational Site

Start Date

2006-10-01

Trial ID

NCT00390910

Treatments Being Tested

Pneumococcal conjugate vaccine GSK1024850A Infanrix hexa

Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule

PHASE2

This is a booster study in 2 groups of healthy children less than 3 years o...

Status

Completed

Location

GSK Investigational Site

Start Date

2007-08-22

Trial ID

NCT00513409

Treatments Being Tested

Synflorix Infanrix Hexa Havrix

Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.

PHASE3

The purposes of this study: * To evaluate the immunogenicity, safety and r...

Status

Completed

Location

GSK Investigational Site

Start Date

2009-02-17

Trial ID

NCT00829010

Treatments Being Tested

Pneumococcal vaccine GSK1024850A Tritanrix-HepB/Hib measles Rotarix Local OPV

Previous Next